Ion Beam Applications
13.74
22-November-24 11:06:40
15 minutes delayed
Stocks
+0.46
+3.46%
Today's range
13.48 - 13.80
ISIN
BE0003766806
Source
Cboe
-
PanTera and TerraPower Isotopes join forces to accelerate access to actinium-225
26 Jun 2023 06:55:31 By Nasdaq GlobeNewswire
-
IBA and PARTICLE initiate FLASH proton therapy Research Partnership
15 Jun 2023 09:00:00 By Nasdaq GlobeNewswire
-
13 Jun 2023 01:00:00 By Nasdaq GlobeNewswire
-
22 May 2023 01:00:00 By Nasdaq GlobeNewswire
-
IBA Business Update – First Quarter 2023
17 May 2023 01:00:00 By Nasdaq GlobeNewswire
-
IBA Reports Full Year 2022 Results
23 Mar 2023 02:00:00 By Nasdaq GlobeNewswire
-
IBA is looking for 100 new collaborators in Belgium by June 2023
14 Mar 2023 09:00:00 By Nasdaq GlobeNewswire
-
CONVOCATION À UNE ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE D’IBA SA
09 Mar 2023 10:55:00 By Nasdaq GlobeNewswire
-
25 Jan 2023 12:00:00 By Nasdaq GlobeNewswire
-
10 Jan 2023 01:00:00 By Nasdaq GlobeNewswire
-
IBA signs contract to install a fully integrated X-ray irradiation solution in France
22 Dec 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Wins 10 Proton Therapy System Contract in Spain
08 Dec 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA – Transparency Notification
07 Dec 2022 11:45:00 By Nasdaq GlobeNewswire
-
28 Nov 2022 11:45:00 By Nasdaq GlobeNewswire
-
IBA Business Update – Third Quarter 2022
17 Nov 2022 01:00:00 By Nasdaq GlobeNewswire
-
13 Oct 2022 01:00:00 By Nasdaq GlobeNewswire
-
ElsMed, Novatec and IBA sign contract to install radiopharmaceutical production center in Georgia
04 Oct 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225
22 Sep 2022 01:00:00 By Nasdaq GlobeNewswire
-
20 Sep 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Reports Half Year 2022 Results
31 Aug 2022 01:00:00 By Nasdaq GlobeNewswire